SCYNEXIS, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from SCYNEXIS, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 305% in 3 years; of every extra $100 of sales, $349 became extra profit. Higher than 91% of Healthcare companies in United States.
- Profit Cash Ratio: Over the last 3 years, every $100 of reported profit came with $83 of operating cash. Lower than 88% of Healthcare companies in United States.
- Cash Cushion Ratio: Cash, after subtracting all debt, equals 100% of its market value (net cash). Higher than 88% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$83Over the last 3 years, every $100 of reported profit came with $83 of operating cash.
Lower than 88% of Healthcare companies in United States.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
$349Sales grew 305% in 3 years; of every extra $100 of sales, $349 became extra profit.
Higher than 91% of Healthcare companies in United States.
Asset Productivity Ratio
+305% / -33%In 3 years sales changed by +305% while total assets changed by -33%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-10.9×Operating cash was negative last year, while some debt falls due within a year.
Higher than 54% of Healthcare companies in United States.
Cash Cushion Ratio
+100%Cash, after subtracting all debt, equals 100% of its market value (net cash).
Higher than 88% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
SCYNEXIS, Inc. made a loss over the last year. SCYNEXIS, Inc. owes $0.11 for every $1 it owns. SCYNEXIS, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossSCYNEXIS, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.57The share price is 0.57 times SCYNEXIS, Inc.'s book value per share, lower than 89% of Healthcare companies in United States.
Market cap
$38 MThe total market value of all of SCYNEXIS, Inc.'s shares at today's price (share price × number of shares), smaller than 77% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$67 MWhat SCYNEXIS, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$6.73Net worth divided by the number of shares. The share price of $3.81 is 0.6 times this, which is the P/B above.
Return on equity (ROE)
-18.4%SCYNEXIS, Inc. lost 18.4% of its shareholders' money over the last year, higher than 66% of Healthcare companies in United States.
Owes vs Owns
0.11×SCYNEXIS, Inc. owes $0.11 for every $1 it owns (low), lower than 86% of Healthcare companies in United States.
Dividend yield
NoneSCYNEXIS, Inc. does not currently pay a dividend.
Revenue growth
+450%Revenue rose 450% in the year to Dec 2025, and grew 59% a year on average over 3 years.
Profit growth
LossSCYNEXIS, Inc. made a loss in each of the last two years.
Profit margin
-41.8%SCYNEXIS, Inc. lost $42 for every $100 of revenue.
Interest cover
Not coveredSCYNEXIS, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashSCYNEXIS, Inc. held $38 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For SCYNEXIS, Inc.: $38 M ÷ $67 M (30 Jun 2026) = 0.6.
What is SCYNEXIS, Inc.'s return on equity?
SCYNEXIS, Inc. lost 18.4% of its shareholders' money over the last year, higher than 66% of Healthcare companies in United States.
How much does SCYNEXIS, Inc. owe compared with what it owns?
SCYNEXIS, Inc. owes $0.11 for every $1 it owns (low), lower than 86% of Healthcare companies in United States.
Does SCYNEXIS, Inc. pay a dividend?
No. SCYNEXIS, Inc. does not currently pay a dividend.
Is SCYNEXIS, Inc.'s revenue growing?
Revenue rose 450% in the year to Dec 2025, and grew 59% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.